Peter Collignon and colleagues 1 aim to improve understanding of global antibiotic resistance drivers by quantifying associations be tween antibiotic resistance and potential contributing factors. A recent systematic review including 565 studies primarily reporting patientlevel data found that anti biotic exposure, underlying disease, and invasive procedures had the greatest evidence of being antibiotic resistance drivers. 2 Given the small evidence base for the role of community factors, 2 we fully concur with Collignon and colleagues about the importance of considering such factors in the spread of antibiotic resistance. 1 However, as the authors recognise, correlation does not imply causation-indeed, national meticillin resistant Staphylococcus aureus rates strongly correlate with unfair play of national football teams. 3 Conversely, it would be a mistake to conclude that weak (or even inverse) correlation between antibiotic use and antibiotic resistance at the national level implies an absence of a strong causal relationship (appendix).
There are several limitations to using current global data. First, important betweencountry differences in the quality and representativeness of data are likely to exist. For example, blood cultures are less frequently taken in resourcepoor settings than in resourcerich settings, and often only when patients do not respond to empirical therapy, leading to inflated estimates of resistance. 4 Moreover, in lower income countries, a substantial proportion of antibiotics used might come from informal providers and not appear in consumption data. Both factors would be expected to weaken associations between reported antibiotic use and resistance, and could lead to positive associations between governance and infrastructure and antibiotic resistance, even if these factors have no effect on antibiotic resistance.
Additionally, comparisons based on nationallevel data can be problematic, particularly when many countries have a sharp divide be tween subpopulations that overuse anti biotics and those that are without access. Patients lacking access to antibiotics are also less likely to have access to healthcare facilities where blood samples are taken. Considering antibiotic consumption only on a national per capita basis could therefore considerably under estimate antibiotic consumption in sub pop u lations where resistance is being measured. Using a multivariable model will unfortunately not overcome such biases.
Finally, the analysis simplifies anti biotic use such that the matter of which antibiotic is consumed is not considered, which will have importance in terms of resistance development. 5 Combined antibiotic consumption measures might therefore not be optimal for determining the contribution of antibiotic consumption to resistance.
While we welcome the central conclusion of the study about the need for efforts to reduce the spread of antibiotic resistance in the community, we are concerned that fundamental limitations of the data could have led to an undervaluing of the role of antibiotic stewardship.
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